glp 1 weight loss fda approved New GLP-1 Pill Foundayo (Orforglipron) Gets Approval for Obesity Is Semaglutide GLP-1 Safe for

Common Reactions Table The FDA has warned about unapproved compounded and unregulated GLP-1 products, which risk contamination and have no therapeutic GLP-1 levels detected in blood tests

THE DISCOVERY Scientists identified a specific subset of brain cells whose activation would be partially responsible for the effects of weight loss drugs like semaglutide (Ozempic, Wegovy)

Another article from the New York Times suggests that it may be helpful in traumatic brain injury, Post Covid-19 brain fog, and arthritis

Biochem Biophys Res Commun 291:13021308 Goldstein BJ, Feinglos MN, Lunceford JK, Johnson J, Williams-Herman DE, Sitagliptin 036 Study Group (2007) Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes

Similarly, recent studies showed that pancreatic GLP-1 does not necessarily change systemic GLP-1 circulating levels in mice 10,50,51

The rising expectation for GLP-1 coverage at work Employee expectations around health benefits are changing fast, especially as newer treatment options become more widely discussed and understood